We are live on ! Find out more
NVCR icon

NovoCure

71 hedge funds and large institutions have $172M invested in NovoCure in 2017 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 26 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,819% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $101K

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

4% more capital invested

Capital invested by funds: $166M → $172M (+$6.4M)

0.24% less ownership

Funds ownership: 24.32%24.08% (-0.24%)

9% less funds holding

Funds holding: 7871 (-7)

17% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 12

42% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 26

Holders
71
Holders Change
-7
Holders Change %
-8.97%
% of All Funds
1.77%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
10
Increased
15
Reduced
26
Closed
12
Calls
$6.99M
Puts
$101K
Net Calls
+$6.89M
Net Calls Change
+$2.64M
Name Holding Trade Value Shares
Change
Change in
Stake
AG
76
Aperio Group
California
-$161K -20,503 Closed
G
77
GenTrust
Florida
-$94K -12,000 Closed
Russell Investments Group
78
Russell Investments Group
United Kingdom
-$80K -10,434 Closed
BCM
79
Bayesian Capital Management
New York
-$80K -10,189 Closed
VKH
80
Virtu KCG Holdings
New York
-$79K -10,100 Closed
MA
81
MUFG Americas
New York
-$7K -916 Closed
BIG
82
Bellwether Investment Group
Tennessee
-$1K -100 Closed
SFS
83
Sowell Financial Services
Arkansas
-$1K -100 Closed

NVCR Hedge Fund Activity: Q1 2017 in Review

71 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q1 2017, worth a combined $172M — up 3.9% from $166M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of NVCR and 10 opened new positions — a net loss of 2 holders — while 26 trimmed existing stakes and 15 added.

The largest buyer was BlackRock, adding an estimated $24.7M. The largest seller was Fidelity Investments, cutting an estimated $2.25M.

  • 71 institutional investors held NovoCure (NVCR) as of Q1 2017, down from 78 in Q4 2016.
  • Funds reported $172M of NovoCure stock for Q1 2017, up 3.9% quarter-over-quarter.
  • 10 funds opened new NovoCure positions in Q1 2017 and 12 closed out, a net change of -2 holders.
  • The largest NovoCure buyer in Q1 2017 was BlackRock, an estimated $24.7M added.
  • The largest NovoCure seller in Q1 2017 was Fidelity Investments, an estimated $2.25M sold.

Based on aggregated 13F filings for Q1 2017.